Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
The return on assets (ROA) is N/A as of Tuesday, October 6, 2026.
RETURN ON ASSETS (ROA)
N/A
Conexeu Sciences Inc.
Market Cap
$98.07M
Return on Assets (ROA)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$97.84M
Return on Assets (ROA)
-65.25%
TTM Avg
-70.13%
3Y Avg
-63.89%
5Y Avg
-46.24%
Market Cap
$97.13M
Return on Assets (ROA)
-46.26%
TTM Avg
-55.26%
3Y Avg
-67.06%
5Y Avg
-56.22%
Market Cap
$98.56M
Return on Assets (ROA)
-206.78%
TTM Avg
-134.13%
3Y Avg
-143.93%
5Y Avg
-119.05%
Market Cap
$93.28M
Return on Assets (ROA)
-1.90%
TTM Avg
1.32%
3Y Avg
1.93%
5Y Avg
1.93%
Market Cap
$102.85M
Return on Assets (ROA)
7.36%
TTM Avg
-1.10%
3Y Avg
-3.18%
5Y Avg
2.66%
Market Cap
$102.86M
Return on Assets (ROA)
-32.73%
TTM Avg
-70.83%
3Y Avg
-106.23%
5Y Avg
-81.00%
Market Cap
$102.84M
Return on Assets (ROA)
-69.14%
TTM Avg
-63.05%
3Y Avg
-52.31%
5Y Avg
-58.69%
Market Cap
$93.63M
Return on Assets (ROA)
-88.24%
TTM Avg
-139.34%
3Y Avg
-100.15%
5Y Avg
-71.92%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Conexeu Sciences Inc. (CNXU) | $98.07M | N/A | N/A | N/A | N/A |
| Korro Bio, Inc. (KRRO)vs › | $97.84M | -65.25% | -70.13% | -63.89% | -46.24% |
| Milestone Pharmaceuticals Inc. (MIST)vs › | $97.13M | -46.26% | -55.26% | -67.06% | -56.22% |
| PolyPid Ltd. (PYPD)vs › | $98.56M | -206.78% | -134.13% | -143.93% | -119.05% |
| Park Dental Partners, Inc. Common Stock (PARK)vs › | $93.28M | -1.90% | 1.32% | 1.93% | 1.93% |
| The Joint Corp. (JYNT)vs › | $102.85M | 7.36% | -1.10% | -3.18% | 2.66% |
| OnKure Therapeutics, Inc. (OKUR)vs › | $102.86M | -32.73% | -70.83% | -106.23% | -81.00% |
| Anixa Biosciences, Inc. (ANIX)vs › | $102.84M | -69.14% | -63.05% | -52.31% | -58.69% |
| Biomea Fusion, Inc. (BMEA)vs › | $93.63M | -88.24% | -139.34% | -100.15% | -71.92% |
| electroCore, Inc. (ECOR)vs › | $91.51M | -86.56% | -66.44% | -84.84% | -75.69% |
ROA
N/A
ROE
N/A
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
